Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA - Publikation - Autoren - KSSG Forschungsdatenbank

Publikation

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA

Wissenschaftlicher Artikel/Review - 29.10.2014

Krop I E, Welslau M, Samant M, Miles D, Lu M, Huober Jens, Guardino E, Blackwell K, Lin N U, Diéras V

Krop, I E

Lin, N U

Blackwell, K

Guardino, E

Huober, Jens

Chefarzt/Chefärztin
Brustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I

Lu, M

Miles, D

Samant, M

Welslau, M

Diéras, V